SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-06-048440
Filing Date
2006-07-24
Accepted
2006-07-24 16:24:43
Documents
7
Period of Report
2006-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-16447_18k.htm 8-K 26669
2 EX-99 a06-16447_1ex99d1.htm EX-99.1 111044
3 EX-99 a06-16447_1ex99d2.htm EX-99.2 9619
4 GRAPHIC g164471kai001.jpg GRAPHIC 1735
5 GRAPHIC g164471kai002.jpg GRAPHIC 4318
6 GRAPHIC g164471kci001.jpg GRAPHIC 1735
7 GRAPHIC g164471kci002.jpg GRAPHIC 4318
  Complete submission text file 0001104659-06-048440.txt   166195
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 06976796
SIC: 2834 Pharmaceutical Preparations